Pain patches provide an alternative option for managing chronic and acute pain conditions. These medication delivery systems have steadily grown in popularity as more effective and convenient treatment options. In this article, we analyze the science behind pain patches and discuss their effectiveness in treating various pain types.
How Do Pain Patches Work?
Pain patches, also known as transdermal patches, work by delivering medications through the skin and into the bloodstream. Most pain patches contain analgesic medications like lidocaine, diclofenac, or ibuprofen in a gel or liquid formulation. The medications are absorbed into three layers of the skin - the epidermis, dermis, and subcutaneous tissue. From there, it enters the blood vessels and lymphatic system to travel throughout the body.
Compared to oral medications, pain patches have several advantages. First, they provide sustained and consistent levels of medication over extended periods, often up to 12 hours or more from a single application. This creates a steadier state of pain relief. Second, avoiding the gastrointestinal tract means fewer side effects like upset stomach. Lastly, patches are convenient as they don't require remembering to take pills multiple times per day.
Are Pain Patches Effective for Different Types of Pain?
Musculoskeletal Pain
Conditions causing muscle and joint pain like arthritis, back pain, and injuries often respond well to pain patches. Studies have found diclofenac and lidocaine patches significantly reduce osteoarthritis knee and low back pain over 4-6 weeks. Ibuprofen patches also match oral ibuprofen for treating ankle sprains or other soft tissue injuries. The localized delivery targets medications directly to painful areas.
Nerve Pain
Neuropathic pain from nerve damage, diabetes, or shingles can be challenging to treat. Lidocaine patches block sodium channels and calm ectopic nerve impulses. Research shows a 5% lidocaine patch provides moderate to good pain relief for postherpetic neuralgia lasting several hours with each application. For localized nerve pain, patches allow high dosage concentrations at injury sites with fewer systemic side effects.
Post-Surgical & Procedural Pain
Managing acute post-surgical or post-procedural pain is another area where patches excel. A lidocaine patch applied before and after a medical procedure numbs the area and eases returning sensation and discomfort. One study gave patients a lidocaine patch after thoracic surgery, finding it significantly decreased pain scores and opioid demand compared to placebo. Patches provide effective localized pain relief as an alternative or addition to oral medications.
Patch Formulations and Application Techniques
Within each pain category, different patch formulations and application techniques impact outcomes. Lidocaine patches commonly come as smaller individual patches meant to treat localized nerve pain or as larger sheets to cover larger wound or injury sites. Diclofenac and ibuprofen patches are usually rectangular strips.
Application instructions vary but generally involve applying the adhesive side of the patch to clean, dry, intact skin and leaving it on for 12 to 24 hours. Some recommendations include shaving hair if needed, avoiding skin creases, and ensuring good contact between the pad and skin. Replacing the patch every day maintains steady medication levels. Combining patches with compression wraps or bandages on injured areas may boost pain relief further. Proper use helps people get the most benefits from these delivery methods.
Risks and Considerations
Like all medications, pain patches do carry some risks, especially with extended use. The most common side effects include skin redness or irritation where the patch adheres. Systemic side effects from lidocaine or NSAIDs absorbed are usually minor but could include nausea, headaches, or dizziness in sensitive individuals. People with liver or kidney disease need to use caution, and patches are not recommended during pregnancy.
Patches may also not be suitable for people with certain skin conditions like eczema or psoriasis where the adhesive could worsen flare-ups. Cost is another factor - while very convenient, patches can be more expensive than oral generics depending on insurance. Doctors consider a patient's overall health, pain characteristics, and lifestyle when deciding if a patch provides a safer, more tailored treatment option over pills. With proper application and monitoring by a healthcare provider, the risks are relatively low.
Overall, well-designed studies show pain patches effectively treat different types of acute and chronic pain, providing relief and convenient dosing over extended periods. When used as directed, they offer patients alternatives with fewer side effects than oral medications. As patch technologies continue advancing with improved adhesive properties and precision delivery systems, their utility in pain management will likely expand further.
Conclusion
In summary, transdermal pain patches have emerged as a valuable treatment modality. By consistently delivering analgesic medications locally through the skin, they target painful areas directly while avoiding liver processing and gastrointestinal absorption problems. For many people, patches provide more efficient relief than oral regimens alone. With broad applications across post-surgical, sports injury, shingles and arthritis related pain profiles, patches allow personalized treatment based on each patient's unique condition. When incorporated judiciously into a comprehensive care plan along with physical therapy, lifestyle changes, and other supportive measures, pain patches can significantly improve quality of life for people dealing with both acute and chronic pain.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the pain relief patches market include Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng and Others.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Pain Relief Patches Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/pain-relief-patches-market/download-sampleMarket Dynamics Global rise in chronic and acute pain-related disorders and various benefits associated with pain relief patches over conventional medications are some of the major factors driving the market growth.
Pain and related disorders are increasing rapidly globally due to changes in lifestyle, lack of physical activity, and a growing number of surgical procedures.
According to the U.S Department of Health and Human Services (HHS), chronic and acute pain affects more Americans than diabetes, cancer, and heart diseases combined.
HHS also reported that pain is the most common reason for visits to healthcare facilities, which makes it the foremost cause of disability in patients, thereby contributing largely to healthcare costs.
March 25, 2019: This report studies the global Pain Relief Patches market status and forecast, categorizes the global Pain Relief Patches market size (value & volume) by manufacturers, type, application, and region.
This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).The major manufacturers covered in this report HisamitsuMylanJohnson & JohnsonActavisLingruiTeikoku SeiyakuSanofiNovartisDownload sample Copy of This Report at: https://www.radiantinsights.com/research/global-pain-relief-patches-market-research-report-2018/request-sample QizhengEndoHuarun 999GSKHaw ParNichibanMentholatum CompanyLaboratoires GenevrierBLUE-EMUGeographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, coveringNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaView Full Report with TOC @ https://www.radiantinsights.com/research/global-pain-relief-patches-market-research-report-2018 On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split intoLidocaine PatchesDiclofenac PatchesIndomethacin PatchesCounter-Irritant PatchesFentanyl PatchesOtherOn the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, includingOTCRxThe study objectives of this report are:To analyze and study the global Pain Relief Patches capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);Focuses on the key Pain Relief Patches manufacturers, to study the capacity, production, value, market share and development plans in future.Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.To define, describe and forecast the market by type, application and region.To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.To identify significant trends and factors driving or inhibiting the market growth.To analyze the opportunities in the market for stakeholders by identifying the high growth segments.To strategically analyze each submarket with respect to individual growth trend and their contribution to the marketTo analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the marketTo strategically profile the key players and comprehensively analyze their growth strategies.In this study, the years considered to estimate the market size of Pain Relief Patches are as follows:History Year: 2013-2017Base Year: 2017Estimated Year: 2018Forecast Year 2018 to 2025About Radiant InsightsRadiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.
We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process.
We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets.
In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.For More Information, Visit Radiant Insights Contact:Michelle ThorasCorporate Sales Specialist, USARadiant Insights, IncPhone: 1-415-349-0054Toll Free: 1-888-202-9519Email: [email protected] Blog URL: http://pharmaceuticalshealthcaremarketforecasts.wordpress.com
GCC Non-opioid Pain Patches Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global GCC Non-opioid Pain Patches industry with a focus on the Chinese market.
The report provides key statistics on the market status of the GCC Non-opioid Pain Patches manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014–2024 global and Chinese GCC Non-opioid Pain Patches market covering all important parameters.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-gcc-non-opioid-pain-patches-2019-2024-642The key points of the report:1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.2.The report explores the international and Chinese major industry players in detail.
In this part, the report presents the company profile, product specifications, capacity, production value, and 2014–2019 market shares for each company.3.Through the statistical analysis, the report depicts the global and Chinese total market of GCC Non-opioid Pain Patches industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.5.The report then estimates 2019–2024 market development trends of GCC Non-opioid Pain Patches industry.
Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.6.The report makes some important proposals for a new project of GCC Non-opioid Pain Patches Industry before evaluating its feasibility.There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.For competitor segment, the report includes global key players of GCC Non-opioid Pain Patches as well as some small players.
At least 11 companies are included:* Pfizer* GlaxoSmithKline* Johnson& Johnson* Novartis AG* Mylan N.V.* Teva Pharmaceutical IndustriesFor complete companies list, please ask for sample pages.The information for each competitor includes:* Company Profile* Main Business Information* SWOT Analysis* Sales, Revenue, Price and Gross Margin* Market ShareFor product type segment, this report listed main product type of GCC Non-opioid Pain Patches market in global and china.
* Product Type I* Product Type II* Product Type IIIFor end use/application segment, this report focuses on the status and outlook for key applications.
